Source: FDA, National Drug Code (US) Revision Year: 2016
Sodium nitroprusside is disodium pentacyanonitrosylferrate(2-) dihydrate, a hypotensive agent whose structural formula is:
whose molecular formula is Na2[Fe(CN)5NO]•2H2O, and whose molecular weight is 297.95. Dry sodium nitroprusside is a reddish-brown powder, soluble in water. In an aqueous solution infused intravenously, sodium nitroprusside is a rapid-acting vasodilator, active on both arteries and veins.
Sodium nitroprusside solution is rapidly degraded by trace contaminants, often with resulting color changes (See DOSAGE AND ADMINISTRATION section). The solution is also sensitive to certain wavelengths of light, and it must be protected from light in clinical use.
NITROPRESS (Sodium Nitroprusside Injection) is available as:
50 mg Flip-top Vial – Each 2 mL vial contains the equivalent of 50 mg sodium nitroprusside dihydrate in sterile water for injection.
| How Supplied |
|---|
|
NITROPRESS (sodium nitroprusside injection) is supplied in amber-colored, single-dose 50 mg/2 mL. Flip-top Vials NDC 0187-4302-02. Manufactured for: Valeant Pharmaceuticals North America LLC, Bridgewater, NJ 08807, USA Manufactured by: Hospira, Inc., McPherson, KS 67460, USA |
| Drug | Countries | |
|---|---|---|
| NITROPRESS | Hong Kong, United States |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
